| 000 | 01662cam a2200313 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 131228s2013 ua do f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2013.Mo.A | ||
| 100 | 0 | _aMona Mahmoud Abdelaziz Abousamra | |
| 245 | 1 | 0 |
_aApplication of nanotechnology for improving efficacy of nystatin pharmaceutical formulations / _cMona Mahmoud Abdelaziz Abousamra ; Supervised Ahmed A. Abdelrahman , Rawia M. Khalil |
| 246 | 1 | 5 | _aتطبيق تكنولوجيا النانو لزيادة فاعلية الصياغات الصيدلية للنستاتين |
| 260 |
_aCairo : _bMona Mahmoud Abdelaziz Abousamra , _c2013 |
||
| 300 |
_a177 P. : _bcharts , photographs ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aNanostructured lipid carrier (NLC), a colloidal carrier system offer many advantages as drug carrier. NLCs were developed to overcome the limitations associated with the SLN. NLC has attracted increasing scientific and commercial attention during the last few years. Nystain is a polyene lipophilic antifungal drug that has been used in the treatment of cutaneous, vaginal and oral fungal infections since 1950 | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aNanostructure lipid carriers | |
| 653 | 4 | _aNystatin | |
| 653 | 4 | _aSolid lipid nanoparticles | |
| 700 | 0 |
_aAhmed Abdelbary Abdelrahman , _eSupervisor |
|
| 700 | 0 |
_aRawia Mohamed Khalil , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44629 _d44629 |
||